Thompson, C., Trneny, M., Morschhauser, F., Salles, G., Reagan, P. M., Hertzberg, M., Zhang, H., Thieblemont, C., Hu, B., Fonseca, G., Kim, W. S., Martelli, M., Mehta, A., Singh, A., Yan, M., Hirata, J., Sugidono, M., Lee, C., Sharman, J. P., Mehta-Shah, N., Flowers, C. R., Tilly, H., Chua, N., Casasnovas, R., Miall, F., Kim, T. M., Tsai, X. C., Nasta, S., Lee, S. T., Friedberg, J. W. (2026). PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study. Blood. https://doi.org/10.1182/blood.2025028848